Press and Media
View the latest AANEM Achievement Award winners, the American Neuromuscular Foundation (ANF) Abstract Award winners, and the latest AANEM news articles on News Express.
Frequently Asked Questions
Q: When will be content of abstracts be viewable, as opposed to just the titles?
A: The abstract content will be available at the annual meeting during the Poster Hall hours. We do not provide abstract presenter information or slides ahead of time. All available information can be found in the AANEM Abstract Guide online when it becomes available.
Q: How do I reach out to abstract or session presenters for an interview?
A: We do not offer member contact information. To connect with abstract or session presenters, review the AANEM Annual Meeting Program when available. Find the topics of interest and connect with the presenter after their lecture or during their abstract poster session time. Currently there is no interview option for virtual attendees.
Q: When can I share information?
A: The embargo on the abstracts themselves is lifted when they have been published in Muscle & Nerve and online in the AANEM Abstract Guide. However, the additional information beyond what is in the abstract itself is still embargoed.
AANEM requires information that goes beyond that which is contained within the abstract, e.g., the release of data not included in the abstract, discussion of the abstract done as part of a scientific presentation, etc. to be embargoed until the start of the annual meeting. Please see the Abstract Embargo Policy.
Q: Will the Abstract Award Reception feature the best posters?
A: The Abstract Award Reception is a social hour in honor of the abstract award winners where all authors, including award winners, will be available to discuss research.
Q: Original research is ONLY presented as posters, correct?
A: Yes - the research is presented in the Poster Hall via abstract posters.
AANEM Hill Day Advances Push for Quality, Safety, and Integrity in EDX Medicine
AANEM members from across the country gathered in Washington, DC, on March 16 for Hill Day, turning a weather-disrupted event into a powerful show of advocacy for patients and the field of EDX medicine. Despite tornado warnings, early office closures, and travel delays due to snowstorms, participants remained committed to ensuring that key messages reached congressional offices.
State Liaison Committee Chair Dr. Chilvana Patel (Texas) captured the spirit of the day, noting, “Despite the unexpected changes, I appreciated everyone’s flexibility and commitment to representing our priorities on behalf of our patients.”
Throughout the day, AANEM’s delegation focused on its legislation, the “Electrodiagnostic Medicine Patient Protection and Fraud Elimination Act” (H.R. 3092), along with related bipartisan efforts to strengthen quality and integrity in EDX testing. Advocates emphasized that qualified physicians, appropriate equipment, and real-time, hands-on testing are essential for accurate diagnoses and high-quality care—ultimately helping to reduce unnecessary costs and the misuse of healthcare resources.
To underscore the importance of this work, attendees shared patient video testimonials, including stories from individuals with ALS who have experienced the serious consequences of delayed or missed diagnoses.
Coordinated Advocacy Across States
Teams met with congressional offices across 13 states, often splitting up to accommodate overlapping schedules and last-minute shifts to virtual formats. In several discussions, delegates also explored opportunities to reengage with CMS leadership—including potential pathways to CMS Administrator Dr. Oz—to encourage stronger enforcement of existing rules governing EDX testing.
A Meaningful Experience for First-Time Advocates
For many participants, Hill Day served as both an educational experience and a powerful reminder of the importance of organized physician advocacy. First-time participant Dr. Zabeen Mahuwala (Kentucky) shared, “Participating in Hill Day demonstrated the collective impact of organized advocacy and reaffirmed my dedication to promoting excellence and integrity in electrodiagnostic medicine.” She emphasized that advocating for appropriate training, accreditation, and adherence to established standards closely aligns with AANEM’s mission.
Keeping the Focus on Patient Safety
AANEM’s Michigan representative, Dr. Anandeep Kumar, reinforced this message in his meetings, noting that “this legislation is fundamentally about the quality of testing and patient safety.” He highlighted that strengthening standards and enforcement can both protect patients and reduce waste and abuse within the healthcare system.
Continuing the Momentum
Looking ahead, AANEM’s health policy team and state liaisons plan to build on these conversations through continued outreach to congressional offices and CMS leadership. As AANEM Executive Director Shirlyn Adkins emphasized, “Our advocacy starts with quality—when patients receive the right test from a qualified physician, we improve outcomes and use healthcare dollars more wisely.”
With sustained member engagement, AANEM will continue advancing policies that support high-quality electrodiagnostic medicine, safeguard patients, and reduce waste and abuse across the healthcare system.